Management of diabetic dyslipidemia

Maria Solano, Ronald B Goldberg

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Identification and management of dyslipidemia is an important element in the multi-factorial approach to prevent coronary heart disease. Diabetic dyslipidemia typically consists of elevated triglyceride, low high-density lipoprotein cholesterol, predominance of small, dense low-density lipoprotein (LDL) particles, and average LDL cholesterol (LDL-C). Lipid-lowering therapy has a beneficial effect on cardiovascular outcomes. Statin treatment is beneficial in patients who are older than 40 years of age, irrespective of the LDL-C value. To achieve lipid targets, attention should be directed first toward nonpharmacologic therapeutic interventions, such as diet, exercise, smoking cessation, weight loss, and improving glycemic control. Although statin therapy is recommended for most subjects, judicious use of combination therapy should be considered in the highest risk subjects.

Original languageEnglish
Pages (from-to)1-25
Number of pages25
JournalEndocrinology and Metabolism Clinics of North America
Volume34
Issue number1
DOIs
StatePublished - Mar 1 2005

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Dyslipidemias
LDL Lipoproteins
Lipids
Nutrition
LDL Cholesterol
HDL Cholesterol
Triglycerides
Therapeutics
Smoking Cessation
Coronary Disease
Weight Loss
Exercise
Diet

ASJC Scopus subject areas

  • Endocrinology
  • Biochemistry

Cite this

Management of diabetic dyslipidemia. / Solano, Maria; Goldberg, Ronald B.

In: Endocrinology and Metabolism Clinics of North America, Vol. 34, No. 1, 01.03.2005, p. 1-25.

Research output: Contribution to journalArticle

@article{24c46cf225f4448188976bf46a51b675,
title = "Management of diabetic dyslipidemia",
abstract = "Identification and management of dyslipidemia is an important element in the multi-factorial approach to prevent coronary heart disease. Diabetic dyslipidemia typically consists of elevated triglyceride, low high-density lipoprotein cholesterol, predominance of small, dense low-density lipoprotein (LDL) particles, and average LDL cholesterol (LDL-C). Lipid-lowering therapy has a beneficial effect on cardiovascular outcomes. Statin treatment is beneficial in patients who are older than 40 years of age, irrespective of the LDL-C value. To achieve lipid targets, attention should be directed first toward nonpharmacologic therapeutic interventions, such as diet, exercise, smoking cessation, weight loss, and improving glycemic control. Although statin therapy is recommended for most subjects, judicious use of combination therapy should be considered in the highest risk subjects.",
author = "Maria Solano and Goldberg, {Ronald B}",
year = "2005",
month = "3",
day = "1",
doi = "10.1016/j.ecl.2005.01.001",
language = "English",
volume = "34",
pages = "1--25",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Management of diabetic dyslipidemia

AU - Solano, Maria

AU - Goldberg, Ronald B

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Identification and management of dyslipidemia is an important element in the multi-factorial approach to prevent coronary heart disease. Diabetic dyslipidemia typically consists of elevated triglyceride, low high-density lipoprotein cholesterol, predominance of small, dense low-density lipoprotein (LDL) particles, and average LDL cholesterol (LDL-C). Lipid-lowering therapy has a beneficial effect on cardiovascular outcomes. Statin treatment is beneficial in patients who are older than 40 years of age, irrespective of the LDL-C value. To achieve lipid targets, attention should be directed first toward nonpharmacologic therapeutic interventions, such as diet, exercise, smoking cessation, weight loss, and improving glycemic control. Although statin therapy is recommended for most subjects, judicious use of combination therapy should be considered in the highest risk subjects.

AB - Identification and management of dyslipidemia is an important element in the multi-factorial approach to prevent coronary heart disease. Diabetic dyslipidemia typically consists of elevated triglyceride, low high-density lipoprotein cholesterol, predominance of small, dense low-density lipoprotein (LDL) particles, and average LDL cholesterol (LDL-C). Lipid-lowering therapy has a beneficial effect on cardiovascular outcomes. Statin treatment is beneficial in patients who are older than 40 years of age, irrespective of the LDL-C value. To achieve lipid targets, attention should be directed first toward nonpharmacologic therapeutic interventions, such as diet, exercise, smoking cessation, weight loss, and improving glycemic control. Although statin therapy is recommended for most subjects, judicious use of combination therapy should be considered in the highest risk subjects.

UR - http://www.scopus.com/inward/record.url?scp=14744287771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14744287771&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2005.01.001

DO - 10.1016/j.ecl.2005.01.001

M3 - Article

VL - 34

SP - 1

EP - 25

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 1

ER -